Market – Page 6

European Commission Imposes €463 Million Fine on Teva for Anti-Competitive Practices in MS Drug Market

9 months ago talkbio0Tagged Commission, competition, Copaxone, Dominance, European (ethnic group), Market, Mississippi (geographic location), MS, tactics, Teva

Teva, European Commission, fine, MS drug, competition tactics, Copaxone, market dominance

Vabysmo’s Growth Pace Slows in Q3, Still on Track for Dominance in Eye Disease Market

9 months ago talkbio0Tagged Age related macular degeneration, Macular edema due to diabetes mellitus, Market, Regeneron, Roche (company), Vabysmo, Vascular Endothelial Growth Factor A

Vabysmo, Roche, Regeneron, Eylea HD, eye disease market, vascular endothelial growth factor A (VEGF-A) therapy, age-related macular degeneration (AMD), diabetic macular edema (DME).

Pfizer Withdraws Sickle Cell Disease Treatment Oxbryta Globally Due to Safety Concerns

10 months ago talkbio0Tagged Anemia, Sickle Cell, Clinical Trials, concerns, Event, Fatal, Generalized, Market, Oxbryta, Pfizer, Safety, vaso-occlusive crises, Withdraw (activity)

Pfizer, Oxbryta, sickle cell disease, global market withdrawal, safety concerns, clinical trials, vaso-occlusive crises, fatal events

Biotech IPO Market Sees Rare Upsurge with Triple Listing Success

10 months ago talkbio0Tagged Bicara Therapeutics, Biosciences, biotech, Drug Industry, Flux, IPO, Market, MBX, Stock Surge, Tripleheader, Zenas BioPharma

Biotech IPO, Market Flux, Tripleheader, Bicara Therapeutics, Zenas BioPharma, MBX Biosciences, Stock Surge, Pharmaceutical Industry

Sanofi’s $1 Billion Bet on Muscular Dystrophy Drug Falters, Fulcrum Shares Plummet

11 months ago talkbio0Tagged Fulcrum, Impact food supplement, Market, muscular dystrophy drug, pharmaceutical failure, sanofi

Sanofi, Fulcrum, muscular dystrophy drug, pharmaceutical failure, stock market impact

Launching a Product in Europe: Understanding Supply Chain Cost Drivers

11 months ago talkbio0Tagged Administration occupational activities, European (ethnic group), Financial cost, Market, Reusable Drivers, Risk, Supply Chain Cost Analysis, supply chain management

Supply Chain Cost Analysis, European Market, Cost Drivers, Supply Chain Management, Risk Management

Biotech IPO Market Sees Shifts in Funding and Investor Appetite

11 months ago talkbio0Tagged clinical-stage assets, Correction - Report timing, crossover, investor, IPOs, Market, venture

biotech IPOs, crossover funding, venture capital, clinical-stage assets, market correction, investor demand

WuXi Biologics’ ADC Spinout Sees Revenue Surge Amid Biosecure Threat

11 months ago talkbio0Tagged bioconjugate, Biological Factors, BIOSECURE, CRDMO, Market, Risk, therapeutic autologous dendritic cells, WuXi

WuXi Biologics, ADC spinout, revenue jump, Biosecure risk, CRDMO, bioconjugate market

Embracing Agility: Critical for the Role of QARA Professional

11 months ago talkbio0Tagged Access, Agility, AI, Artificial Intelligence, Communication, Diversity, Inclusion, Leadership, Market, professional occupation status, QARA, quality assurance, Regulatory Affairs, regulatory strategy, Technology

QARA Professional, Agility, Quality Assurance, Regulatory Affairs, Market Access, Innovative Therapeutic Solutions, AI, Technology, Regulatory Strategy, Leadership, Communication, Diversity, Inclusion.

Evotec Announces 400 Job Cuts Amid Market Challenges

12 months ago talkbio0Tagged Challenge, Contract agreement, development aspects, Drug Discovery, Evotec, Manufacture, Market, restructuring

Evotec, job cuts, market challenges, restructuring, drug discovery, contract development, manufacturing